Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Tonix Pharmaceuticals Holding stock

Learn how to easily invest in Tonix Pharmaceuticals Holding stock.

Tonix Pharmaceuticals Holding is a biotechnology business based in the US. Tonix Pharmaceuticals Holding shares (TNXP) are listed on the NASDAQ and all prices are listed in US Dollars. Tonix Pharmaceuticals Holding employs 117 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Tonix Pharmaceuticals Holding stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – TNXP. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Tonix Pharmaceuticals Holding stock price (NASDAQ: TNXP)

Use our graph to track the performance of TNXP stocks over time.

Tonix Pharmaceuticals Holding shares at a glance

Information last updated 2023-09-24.
Latest market close$0.79
52-week range$0.77 - $9.81
50-day moving average $1.12
200-day moving average $2.94
Wall St. target price$11.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-8.44

Buy Tonix Pharmaceuticals Holding stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Finder Rating: 4.1 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Finder Rating: 4.2 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Tonix Pharmaceuticals Holding stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tonix Pharmaceuticals Holding price performance over time

Historical closes compared with the close of $0.79 from 2023-09-26

1 week (2023-09-20) -8.14%
1 month (2023-08-25) -14.13%
3 months (2023-06-27) -43.97%
6 months (2023-03-27) 41.07%
1 year (2022-09-27) 46.30%
2 years (2021-09-27) 27.42%
3 years (2020-09-25) 0.848
5 years (2018-09-27) 60

Tonix Pharmaceuticals Holding financials

Gross profit TTM $0
Return on assets TTM -35.91%
Return on equity TTM -60.97%
Profit margin 0%
Book value $13.05
Market Capitalization $14.4 million

TTM: trailing 12 months

Tonix Pharmaceuticals Holding share dividends

We're not expecting Tonix Pharmaceuticals Holding to pay a dividend over the next 12 months.

Have Tonix Pharmaceuticals Holding's shares ever split?

Tonix Pharmaceuticals Holding's shares were split on a 16:100 basis on 9 May 2023. So if you had owned 100 shares the day before before the split, the next day you'd have owned 16 shares. This wouldn't directly have changed the overall worth of your Tonix Pharmaceuticals Holding shares – just the quantity. However, indirectly, the new 525% higher share price could have impacted the market appetite for Tonix Pharmaceuticals Holding shares which in turn could have impacted Tonix Pharmaceuticals Holding's share price.

Tonix Pharmaceuticals Holding share price volatility

Over the last 12 months, Tonix Pharmaceuticals Holding's shares have ranged in value from as little as $0.77 up to $9.8125. A popular way to gauge a stock's volatility is its "beta".

TNXP.US volatility(beta: 2.21)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tonix Pharmaceuticals Holding's is 2.2147. This would suggest that Tonix Pharmaceuticals Holding's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Tonix Pharmaceuticals Holding overview

Tonix Pharmaceuticals Holding Corp. , a clinical-stage biopharmaceutical company, develops therapeutics and vaccines to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, a humanized monoclonal antibody targeting CD40-ligand being developed to treat autoimmune conditions. Its rare disease portfolio comprises TNX-2900 for the treatment of Prader-Willi syndrome. The company's infectious disease pipeline includes TNX-801, a vaccine to prevent smallpox and monkeypox; TNX-1840 and TNX-1850 that are live virus vaccines based on its recombinant pox vaccine (RPV) platform for COVID-19; and TNX-102 SL, a CNS product candidate to treat Long COVID, a chronic post-acute COVID-19 condition. Its CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions, including TNX-102 SL, which is in mid-Phase 3 development for the management of fibromyalgia; TNX-1900 that is in development for the prevention of migraine headache; and TNX-1300, a recombinant protein enzyme to treat cocaine intoxication.

Frequently asked questions

What percentage of Tonix Pharmaceuticals Holding is owned by insiders or institutions?
Currently 0.044% of Tonix Pharmaceuticals Holding shares are held by insiders and 11.944% by institutions.
How many people work for Tonix Pharmaceuticals Holding?
Latest data suggests 117 work at Tonix Pharmaceuticals Holding.
When does the fiscal year end for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding's fiscal year ends in December.
Where is Tonix Pharmaceuticals Holding based?
Tonix Pharmaceuticals Holding's address is: 26 Main Street, Chatham, NJ, United States, 07928
What is Tonix Pharmaceuticals Holding's ISIN number?
Tonix Pharmaceuticals Holding's international securities identification number is: US8902608624
What is Tonix Pharmaceuticals Holding's CUSIP number?
Tonix Pharmaceuticals Holding's Committee on Uniform Securities Identification Procedures number is: 890260102

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site